Ehrlich W, Mangir M, Bunte T
Institut für Biochemie und Molekularbiologie, Fachbereich Biologie, FU Berlin.
Z Rheumatol. 1988;47 Suppl 1:9-12.
The amino-thiol-containing compound D-penicillamine is used as a disease-modifying drug in the treatment of rheumatoid arthritis. In the present study the effects of D-penicillamine on Chinese hamster ovary cells (CHO) were evaluated. It could be shown that only high doses, i.e. doses exceeding the therapeutically occurring plasma concentration many times, were toxic to the cells, leading to an early death of the cells. High doses (1,500 micrograms/ml) of D-penicillamine caused an inhibition of the endogenous pyrimidine synthesis of the CHO and lead to a drastic reduction of the cellular protein biosynthesis. The observations made are discussed with respect to formerly published data about mutagenicity and carcinogenicity of D-penicillamine.
含氨基硫醇的化合物D-青霉胺被用作治疗类风湿性关节炎的病情缓解药物。在本研究中,评估了D-青霉胺对中国仓鼠卵巢细胞(CHO)的影响。结果表明,只有高剂量,即比治疗时出现的血浆浓度高出许多倍的剂量,才对细胞有毒性,导致细胞过早死亡。高剂量(1500微克/毫升)的D-青霉胺会抑制CHO细胞内源性嘧啶合成,并导致细胞蛋白质生物合成急剧减少。结合先前发表的关于D-青霉胺致突变性和致癌性的数据,对这些观察结果进行了讨论。